Source: Pharamceutical Technology

Incyte: Incyte and Genesis collaborate on small-molecule medicines

Incyte and Genesis have entered a strategic partnership for the research, discovery and development of new small-molecule medicines.

Read full article »
Annual Revenue
$1.0-5.0B
Employees
1.0-5.0K
Herve Hoppenot's photo - President & CEO of Incyte

President & CEO

Herve Hoppenot

CEO Approval Rating

74/100

Read more